Ocular adverse events associated with immune checkpoint inhibitors, a scoping review

INTRODUCTION: Immune checkpoint inhibitors (ICIs) have become an important part of the treatment of multiple cancers, especially for advanced melanoma and non-small cell lung cancer. Some tumors are capable of escaping immunosurveillance by stimulating checkpoints on T-cells. ICIs prevent activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Martens, A., Schauwvlieghe, P. P., Madoe, A., Casteels, I., Aspeslagh, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947214/
https://www.ncbi.nlm.nih.gov/pubmed/36811715
http://dx.doi.org/10.1186/s12348-022-00321-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947214/
https://www.ncbi.nlm.nih.gov/pubmed/36811715
http://dx.doi.org/10.1186/s12348-022-00321-2

Ejemplares similares